The treatment of acne vulgaris, one of the most common dermatological conditions worldwide, depends on scientifically validated acne treatment ingredients that address the multiple pathogenic factors involved in this chronic inflammatory condition. Pharmaceutical grade azelaic acid has emerged as a cornerstone of acne therapy, offering a unique combination of antibacterial, anti-inflammatory, and anti-keratinizing effects that target the key mechanisms of acne pathogenesis . The global pharmaceutical grade azelaic acid market was valued at USD 17 million in 2023 and is forecast to reach USD 23 million by 2030, with a CAGR of 4.8% . This growth reflects the increasing recognition of azelaic acid's therapeutic value and expanding applications in dermatology.

Azelaic acid's efficacy in acne treatment is supported by extensive clinical evidence. Clinical trials have found significant reductions in the density of Cutibacterium acnes (by about 30- to 44-fold) after topical application of 20% azelaic acid, along with reductions in other microorganisms including Micrococcaceae and Staphylococcus . A 12-week study of twice-daily azelaic acid 20% cream demonstrated that a significantly higher proportion of patients with papulopustular acne achieved a "good-to-excellent clinical response" (64%) compared with vehicle (36%) . This clinical efficacy, combined with a favorable safety profile, positions azelaic acid as an essential tool in the dermatologist's armamentarium.

Mechanisms of Action in Acne Treatment

Pharmaceutical grade azelaic acid exerts its therapeutic effects through multiple mechanisms that address the complex pathophysiology of acne. Its primary value in treating acne is through its antimicrobial effect, largely exerting a bacteriostatic effect against Cutibacterium acnes . While azelaic acid is a weaker antibacterial agent compared to true antibiotics, it can remain effective against resistant bacteria, offering a valuable option in cases where traditional antibiotics fail . This characteristic, combined with its non-antibiotic mechanism of action—which involves disrupting mitochondrial respiration and changing intracellular pH—makes azelaic acid an important tool in decreasing bacterial resistance .

Beyond its antibacterial effects, azelaic acid serves as an exfoliant that promotes cell turnover, targeting the pathogenic factor of hyperkeratinization. Studies have shown that it modifies epidermal differentiation by normalizing filaggrin distribution, resulting in a decrease in stratum corneum thickness . This effect is related to changes in kallikrein-5 (KLK5) and cathelicidin, both of which are involved in epidermal proliferation . Additionally, azelaic acid exhibits anti-inflammatory activity by interfering with the NF-κB/MAPK inflammatory signaling pathway and inhibiting the release of reactive oxygen species (ROS) from neutrophils . It also inhibits the expression of toll-like receptor 2 (TLR2), reducing the inflammatory response triggered by Cutibacterium acnes .

Formulation Science and Clinical Application

Pharmaceutical grade azelaic acid formulations have evolved significantly to address the ingredient's inherent formulation challenges, including limited solubility and skin penetration. The development of innovative delivery systems has enhanced therapeutic efficacy while reducing side effects. Research has demonstrated that azelaic acid-based lyotropic liquid crystals (LLCs) can significantly improve drug release and skin penetration, with the LLC gel formulation showing 91.07% drug release after 24 hours compared to 23.29% for pure azelaic acid . The dermatopharmacokinetic study revealed enhanced drug retention in the dermal layer for the LLC gel formulation (146.121 ± 21.13 µg/cm²) compared to marketed gel (58.58 ± 15.95 µg/cm²), suggesting improved therapeutic outcomes .

Pharmaceutical grade azelaic acid is available in multiple formulations, including 20% cream for acne vulgaris and 15% gel for rosacea. Azelaic acid 20% cream is indicated for the treatment of mild-to-moderate acne vulgaris for twice-daily use . While azelaic acid is generally well tolerated, dose-dependent side effects such as skin irritation, dryness, scaling, and erythema can occur, particularly with higher concentration formulations . The development of novel drug delivery systems that enhance skin penetration and retention while minimizing side effects represents a significant advance in acne treatment. Pharmaceutical grade azelaic acid will continue to be an essential component of dermatological care, offering effective, well-tolerated treatment options for acne and related skin conditions.